Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Dusseldorf - Delayed Quote EUR

Karyopharm Therapeutics Inc (25K.DU)

Compare
0.5440
+0.0052
+(0.97%)
At close: February 25 at 7:30:21 PM GMT+1
Loading Chart for 25K.DU
  • Previous Close 0.5388
  • Open 0.0000
  • Bid --
  • Ask --
  • Day's Range 0.0000 - 0.0000
  • 52 Week Range 0.0000 - 21.7650
  • Volume 0
  • Avg. Volume 10
  • Market Cap (intraday) --
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) --
  • EPS (TTM) --
  • Earnings Date Feb 19, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Recent News: 25K.DU

View More

Performance Overview: 25K.DU

Trailing total returns as of 4/4/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

25K.DU
94.59%
S&P 500 (^GSPC)
13.73%

1-Year Return

25K.DU
97.10%
S&P 500 (^GSPC)
1.42%

3-Year Return

25K.DU
99.51%
S&P 500 (^GSPC)
10.72%

5-Year Return

25K.DU
99.77%
S&P 500 (^GSPC)
103.89%

Compare To: 25K.DU

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 25K.DU

View More

Valuation Measures

Annual
As of 4/4/2025
  • Market Cap

    29.42M

  • Enterprise Value

    107.12M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.22

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    0.81

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    --

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    --

  • Diluted EPS (ttm)

    --

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    --

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: 25K.DU

View More

Company Insights: 25K.DU

Research Reports: 25K.DU

View More